Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dalpiciclib (SHR-6390) hydrochloride is a highly selective, orally active CDK4/6 inhibitor with IC50 values of 12.4 nM and 9.9 nM, respectively, and is capable of acting as an antitumor agent in breast and esophageal squamous cell carcinomas.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,490.00 | |
50 mg | 10-14 weeks | $ 1,940.00 | |
100 mg | 10-14 weeks | $ 3,110.00 |
Description | Dalpiciclib (SHR-6390) hydrochloride is a highly selective, orally active CDK4/6 inhibitor with IC50 values of 12.4 nM and 9.9 nM, respectively, and is capable of acting as an antitumor agent in breast and esophageal squamous cell carcinomas. |
Molecular Weight | 483.01 |
Formula | C25H31ClN6O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dalpiciclib hydrochloride inhibitor inhibit